Back to top
more

Cerner Corporation (CERN)

(Delayed Data from NSDQ)

$68.47 USD

68.47
2,167,881

+0.46 (0.68%)

Updated May 3, 2019 04:00 PM ET

After-Market: $68.46 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks News

Here's Why You Should Retain Nevro (NVRO) Stock For Now

Investors continue to be optimistic about Nevro (NVRO) owing to its strength in the global SCS market.

Here's Why You Should Retain Bio-Rad (BIO) Stock for Now

Investors are optimistic about Bio-Rad's (BIO) strong growth within Life Science and Clinical Diagnostics segments across all regions.

Here's Why You Should Add Quidel (QDEL) Stock To Your Portfolio

Investors continue to be optimistic about Quidel (QDEL) owing to its strong diagnostics portfolio.

Cerner (CERN) to Report Q4 Earnings: What's in the Offing?

Cerner's (CERN) fourth-quarter results are likely to reflect gains from strategic deals.

Medtronic (MDT) Reports First Procedure in Europe With Hugo RAS

Medtronic's (MDT) Hugo RAS system was utilized to perform robotic prostatectomy at OLV Hospital in Aalst, Belgium.

Here's Why You Should Retain QIAGEN (QGEN) Stock for Now

Investors continue to be optimistic about QIAGEN's (QGEN) progress with testing solutions and strategic collaborations.

BD (BDX) Beats on Q1 Earnings and Revenues, Raises FY22 View

The majority of BD's (BDX) core units witness strong revenue growth in the fiscal first quarter.

Abiomed (ABMD) Beats on Q3 Earnings, Narrows FY22 Guidance

Abiomed's (ABMD) strength in Impella product revenues drives its Q3 top line.

McKesson (MCK) Earnings and Revenues Beat Estimates in Q3

McKesson's (MCK) fiscal third-quarter 2022 results benefit from considerable growth across all segments.

Change Healthcare (CHNG) Q3 Earnings in Line, Revenues Beat

Change Healthcare's (CHNG) fiscal third-quarter results benefit from solid performance across Software and Analytics, Network Solutions and Technology-Enabled segments.

Cardinal Health (CAH) Q2 Earnings and Revenues Top Estimates

Cardinal Health's (CAH) fiscal second-quarter results benefit from a solid performance in the Pharmaceutical segment.

Cerner (CERN) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Cerner (CERN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Humana (HUM) Q4 Earnings Beat Estimates on Membership Growth

Humana (HUM) is taking multiple initiatives like cost savings and others to generate $1 billion additional value to fund the Medicare Advantage business and boost Healthcare Services capabilities.

Boston Scientific (BSX) Q4 Earnings Top Estimates, Margins Up

Boston Scientific (BSX) registers a year-over-year improvement in organic sales, indicating a strong rebound in legacy business from pandemic mayhem.

Here's Why You Should Retain Merit Medical (MMSI) Stock For Now

Investors continue to be optimistic about Merit Medical (MMSI) owing to its progress in the WAVE study and a strong product portfolio.

AmerisourceBergen (ABC) Q1 Earnings Lag Estimates, Revenues Beat

AmerisourceBergen's (ABC) fiscal first-quarter results benefit from segmental growth.

PerkinElmer (PKI) Q4 Earnings and Revenues Surpass Estimates

PerkinElmer's (PKI) fourth-quarter results benefit from solid performance at Discover & Analytics Solutions business.

Catalent (CTLT) Q2 Earnings Top Estimates, FY22 View Up

Catalent's (CTLT) robust performance across most of its segments drives its second-quarter fiscal 2022 top line.

Cerner (CERN) Stock Sinks As Market Gains: What You Should Know

Cerner (CERN) closed the most recent trading day at $91.20, moving -0.21% from the previous trading session.

McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Quest Diagnostics (DGX) COVID Test Sales Aid Amid Price Woe

Quest Diagnostics' (DGX) base business continues to improve, signifying the ongoing recovery trend of the industry.

NextGen's (NXGN) Integrated Platform to Enhance Tribal Health

NextGen's (NXGN) integrated platform was adopted by a community health center in Northern California to meet the health requirements of American Indians/Alaska Natives.

AutoZone and National Beverage Corp. highlighted as Zacks Bull and Bear of the Day

AutoZone and National Beverage Corp. highlighted as Zacks Bull and Bear of the Day.

CVS Health (CVS) Hits a 52-Week High: What's Driving It?

Strength across the retail segment and growing specialty pharmacy revenues are driving CVS Health's (CVS) top line.

Thermo Fisher (TMO) Base Sales Rebound, Bioproduction in Focus

Thermo Fisher (TMO) is currently expanding its bioproduction purification resin capacity, which is used in the mRNA manufacturing process.